Clinical Trials

SEC recommends DCGI to approve Bharat Biotech's Covaxin for children between 2-18 years of age

If approved, the two-dose vaccine will be given to children within 20 days apart.

Hopeful of beginning vaccination for children aged 5-11 by end-2021, says FDA vaccine chief

In the US, anyone 12 and older is eligible for the vaccine but with the new variants and schools reopening, parents are wondering when younger children can get the shots.

Trial participants will be issued digital vaccine certificates: Health Ministry

The ICMR was designated as the nodal agency for the collection of vaccination data for such participants by the ministry.

Azerbaijan trial studying effects of combined Sputnik and AstraZeneca vaccines reports positive results

When contacted for their response to the latest development, both Serum Institute of India and Dr Reddy's Laboratories refused to comment at this time.

WHO's Solidarity trial will test three new potential COVID-19 drugs in new phase

The study began in June 2021 and will continue till May 2022 and is being conducted in over 600 hospitals in 52 countries.

COVID-19 survivors are twice as likely to get re-infected, are urged to get vaccinated

Vaccinated survivors can make antibodies that can recognize all kinds of variants even if you were never exposed to the variant.

Bharat Biotech’s intranasal vaccine for COVID-19: Everything we know so far about BBV154

The intranasal vaccine BBV154 is being tested to check if it prevents infection, halts person-to-person transmission, and progression of COVID-19.

CureVac’s COVID-19 mRNA vaccine disappoints in preliminary results as it shows 47 percent efficacy

Franz-Werner Haas, chief executive blamed the results on the high number of variants in the countries where the vaccine was tested.

Bharat Biotech's Covaxin trials on children between 2-18 years of age amounts to homicide: Plea in Delhi HC

Petitioner Sanjeev Kumar said the children could suffer adverse health or mental effects due to the vaccine testing.

Health ministry to buy 30 cr COVID-19 vaccine doses from Biological-E for Rs 1,500 cr

The vaccine recently got the nod of approval for phase-3 clinical trials after showing promising results in phase 1 and 2.